Company facts
- Headquarters
- San Diego, California
- Most recent report
- 8-K, filed Oct 16, 2026
- Incorporated
- Delaware
- Filings on record
- 47 filings
- On EDGAR
- CIK 1997038
- Fiscal year ends
- December
- Filer status
- N/A
News 1
Prospectuses and Registrations 4
Ownership 8 of 30
- SCHEDULE 13G Large holder reported a passive stake Nov 9, 2026
- 4 Insider reported a trade Oct 19, 2026
- 4 Insider reported a trade Oct 19, 2026
- 4 Insider reported a trade Oct 19, 2026
- 4 Insider reported a trade Oct 19, 2026
- 4 Insider reported a trade Oct 19, 2026
- 4 Insider reported a trade Oct 16, 2026
- 4 Insider reported a trade Oct 16, 2026
Other 8 of 12
- EFFECT Notice that a registration became effective Oct 14, 2026
- CERT Exchange certified a listing Oct 14, 2026
- 8-A12B Registration of a security for exchange listing Oct 13, 2026
- D Sep 9, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Aug 28, 2026
- DRS Draft registration statement, submitted confidentially Jul 24, 2026
- D Apr 8, 2026
- D Nov 21, 2025
Everything here comes from Iambic Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.